Suppr超能文献

微环境中的β-TrCP通过抑制氨基酸转运引发人类非小细胞肺癌中的CD8 T细胞耗竭。

Microenvironmental β-TrCP negates amino acid transport to trigger CD8 T cell exhaustion in human non-small cell lung cancer.

作者信息

Li Ge, Wen Zhenke, Xiong Sidong

机构信息

The Fourth Affiliated Hospital of Soochow University, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Soochow University, Suzhou, China; Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.

The Fourth Affiliated Hospital of Soochow University, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Soochow University, Suzhou, China; Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, China.

出版信息

Cell Rep. 2025 Jan 28;44(1):115128. doi: 10.1016/j.celrep.2024.115128. Epub 2025 Jan 3.

Abstract

CD8 T cell exhaustion (Tex) has been widely acknowledged in human cancer, while the underlying mechanisms remain unclear. Here, we demonstrate that reduced amino acid (aa) metabolism and mTOR inactivation are accountable for Tex in human non-small cell lung cancer (NSCLC). NSCLC cells impede the T cell-intrinsic transcription of SLC7A5 and SLC38A1, disrupting aa transport and consequently leading to mTOR inactivation. Further, the ubiquitination of YAP1 protein is the basis for NSCLC-mediated transcriptional inhibition of aa transporters. Mechanistically, NSCLC cells transfer β-TrCP-containing exosomes into T cells, inducing YAP1 ubiquitination and Tex. Consequently, inhibiting cancer-associated β-TrCP effectively restores the anti-tumor immune response of CD8 T cells and curtails tumor growth in NSCLC patient-derived organoids. Together, our findings highlight a β-TrCP-dependent mechanism in steering intrinsic metabolic adaptation and CD8 Tex, emphasizing microenvironmental β-TrCP as an immune checkpoint for therapeutic exploration against human NSCLC.

摘要

CD8 T细胞耗竭(Tex)在人类癌症中已得到广泛认可,但其潜在机制仍不清楚。在这里,我们证明氨基酸(aa)代谢减少和mTOR失活是人类非小细胞肺癌(NSCLC)中Tex的原因。NSCLC细胞阻碍SLC7A5和SLC38A1的T细胞内在转录,破坏aa转运,从而导致mTOR失活。此外,YAP1蛋白的泛素化是NSCLC介导的aa转运体转录抑制的基础。从机制上讲,NSCLC细胞将含β-TrCP的外泌体转移到T细胞中,诱导YAP1泛素化和Tex。因此,抑制癌症相关的β-TrCP可有效恢复CD8 T细胞的抗肿瘤免疫反应,并抑制NSCLC患者来源类器官中的肿瘤生长。总之,我们的研究结果突出了一种β-TrCP依赖的机制,该机制可引导内在代谢适应和CD8 Tex,强调微环境β-TrCP作为针对人类NSCLC进行治疗探索的免疫检查点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验